Study uncovers reasons why certain cancer treatments fail in some patients
Drugs that inhibit enzymes called tyrosine kinases are among the most effective targeted cancer treatments. Yet, they only benefit about 40 to 80 percent of the patients expected to respond. MIT researchers found that many tumors keep growing by activating an alternative survival pathway, even when drugs block the main pathway. “The cells seem to […]
Study uncovers reasons why certain cancer treatments fail in some patients Read More »









